Expanded Field Swept-source Optical Coherence Tomography Angiography in the Assessment of Proliferative Diabetic Retinopathy and Associated Complications: A Review.

Edward S Lu, Xinyi Ding, Francesco Romano, John B Miller

Journal: International ophthalmology clinics 2025;65(3):12-16

PMID: 40601505

Abstract

Retinal imaging plays a critical role in the detection and management of proliferative diabetic retinopathy (PDR). Commonly used imaging modalities in the retina clinic include ultra-widefield fundus photography, ultra-widefield fluorescein angiography (FA), and optical coherence tomography (OCT). OCT angiography (OCTA) provides a noninvasive method to assess the retinal microvasculature and detect vascular alterations, including retinal neovascularization (NV). More recently, the emergence of expanded field swept-source OCTA (SS-OCTA) has offered faster en-face and cross-sectional imaging of the retina with a broader field of view. Prior reviews have highlighted the role of SS-OCTA in assessing associated lesions of PDR, including NV, microaneurysms, foveal avascular zone, intraretinal microvascular abnormalities, and capillary non-perfusion. In this review, we explore the clinical applications of expanded field SS-OCTA in characterizing NV morphology, comparing NV detection to FA, and offering potential imaging biomarkers associated with vision-threatening complications of PDR, including vitreous hemorrhage, neovascular glaucoma, and tractional retinal detachment.

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

Address: Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA.; Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA.; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.